颈内动脉闭塞患者最佳管理的国际多学科共识
该国际多学科共识基于28项颈内动脉闭塞(ICAO)研究及60名专家的投票,认为ICAO是晚期系统性动脉粥样硬化的表现而非孤立脑血管病。管理应以最佳药物治疗为基石,选择性考虑保守或侵入性干预,并建议建立全球登记以指导未来试验。
要点
- ICAO是晚期系统性动脉粥样硬化的标志,需全面评估多系统血管病。
- 最佳药物治疗(抗血小板、降压、他汀、控糖)是ICAO管理的基石。
- 血运重建应集中在具备术中神经监测和血流动力学控制的血管神经中心。
核心结论
- ICAO是晚期系统性动脉粥样硬化的标志,管理应强调全面评估多系统血管病和积极改善心血管危险因素。
- 最佳药物治疗是ICAO管理的基石,保守或侵入性干预需根据症状状态、解剖因素、手术风险和机构专长选择性考虑。
研究设计与样本
- 检索PubMed/MEDLINE、Scopus和Embase(1980-2025年)得10588条结果,最终纳入28项专门针对ICAO患者队列的研究进行定量和定性综合分析。
- 随后向来自美国(n=21)和多个欧洲国家(n=42)的63名参与者发放问卷,3人未回复,共识协调员弃权,最终投票小组为60人。
主要发现
- 纳入研究中,ICAO患者出现神经系统症状的比例范围为38%至100%,约24%至27%的患者诊断时无症状。
- 17项预设声明中11项(64.7%)达到共识(≥75%)。
- 56/60(93.3%)参与者同意ICAO是晚期动脉粥样硬化的系统性表现而非孤立脑血管病理。
- 59/60(98.3%)同意 duplex 超声应作为疑似ICAO的一线诊断工具,必要时用CTA或MRA确认。
- 59/60(98.3%)同意最佳药物治疗是ICAO管理的基石;60/60(100%)同意应强烈建议所有ICAO患者优化生活方式和代谢危险因素。
关键数值与推荐
- 共识阈值定义为≥75%,17项预设声明中11项(64.7%)达到共识。
- 56/60(93.3%)同意ICAO是系统性晚期动脉粥样硬化表现。
- 59/60(98.3%)同意 duplex 超声为一线诊断工具,必要时CTA/MRA确认。
- 59/60(98.3%)同意最佳药物治疗是基石;60/60(100%)同意强烈建议生活方式和代谢危险因素优化。
- 57/60(95.0%)同意ICAO血运重建应集中在配备术中神经监测和先进血流动力学控制的血管神经中心。
临床怎么用
- 对疑似ICAO,首选 duplex 超声诊断,必要时以CTA或MRA确认。
- 所有ICAO患者均应接受最佳药物治疗(抗血小板、降压、他汀、控糖)及生活方式和代谢危险因素优化。
- 血运重建应仅在具备术中神经监测和先进血流动力学控制的血管神经中心选择性开展。
- 当前ICAO干预证据不足,建议建立全球登记记录结局并指导未来试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe atherosclerotic internal carotid artery stenosis may progress to complete internal carotid artery occlusion (ICAO). Therefore, ICAO represents an advanced form of carotid artery disease. We sought to investigate the association between ICAO with atherosclerotic disease in other arterial beds and vascular risk factors and to identify the patient implications of the diagnosis of ICAO. METHODS: Using the term "Internal carotid artery occlusion," a search of PubMed/MEDLINE, Scopus, and Embase between 1980 and 2025 revealed 10,588 results. After exclusion of case reports, letters to the Editor and Editorials, 5771 reports were identified. Following meticulous screening of the identified reports, 28 studies specifically addressing patient with ICAO cohorts were included in the final analysis. A quantitative and qualitative synthesis analysis was performed. A questionnaire was subsequently developed and sent out to 63 participants from the United States (n = 21) and several European countries (n = 42), aiming to achieve consensus regarding the optimal management of patients with ICAO. Three participants did not respond. The Consensus Coordinator abstained from voting to avoid introducing bias, resulting in a final voting panel of 60 participants. RESULTS: Across included studies, the proportion of patients with ICAO presenting with neurologic symptoms varied widely, ranging from 38% to 100%, whereas approximately 24% to 27% of patients were asymptomatic at the time of diagnosis. Consensus (≥75%) was achieved in 11 of the 17 (64.7%) prespecified statements. Most participants agreed that atherosclerotic ICAO represents a systemic manifestation of advanced atherosclerosis rather than isolated cerebrovascular pathology (56/60; 93.3%). Duplex ultrasound study should be used as the first-line diagnostic tool for suspected ICAO, with computed tomography angiography or magnetic resonance angiography confirmation if necessary (59/60; 98.3%). Optimal medical therapy (including antiplatelet, antihypertensives, statins, and glycemic control) remains the cornerstone of ICAO management (59/60; 98.3%). Lifestyle and metabolic risk factor optimization, smoking cessation, optimizing body weight, a healthy diet and exercise, should be strongly advised in all patients with ICAO (60/60; 100%). Most participants concurred that ICAO revascularization should be centralized in specialized vascular-neuro centers equipped for intraoperative neuromonitoring and advanced hemodynamic control (57/60; 95.0%). Finally, most participants agreed that current evidence for ICAO intervention is insufficient and that a global registry should be created to record outcomes and guide future trials (56/60; 93.3%). CONCLUSIONS: This international, multispecialty consensus highlights ICAO as a marker of advanced, systemic atherosclerosis. Management should emphasize comprehensive evaluation for multisystem vascular disease and aggressive modification of cardiovascular risk factors. Best medical therapy remains the cornerstone of the management of patients with ICAO, with conservative or invasive interventions considered selectively based on symptom status, anatomic considerations, procedural risk, and institutional expertise, to reduce the overall cardiovascular disease burden.
引用
- Paraskevas KI, Sultan S, Podlasek A, et al. An international, multispecialty consensus document on the optimal management of patients with internal carotid artery occlusion. J Vasc Surg. 2026. PMID: 42229617. doi:10.1016/j.jvs.2026.04.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。